Category Archives: Business and Investments

Latest From Business and Investments

Nominate Your Company in the Buzz of BIO Contest

This year at BIO’s International Convention, we’re giving you the chance to win free registration to the event!  This would include access to BIO One-on-One Partnering, plus the chance to give a Company Presentation – if you win, both are COMPLETELY FREE! What do you have to do?  It’s easy – nominate your company here.  Enter a few pieces of information about who you are and what you do.  Then industry leaders and experts will Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

It’s Official

Partnering is a go for the BIO Business Forum! Stay tuned for blog posts about some of the new features you’ll be seeing this year. If you missed the announcement, take a look here and sign up for future emails from the International Convention team. Happy Partnering!

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , ,

Is Partnering Going Live for BIO Business Forum?

There’s been a rumor buzzing through the halls of the BIO offices the past few days. It sounds like the One-on-One Partnering System will be launching early for the International Convention’s BIO Business Forum. Partly due to the fact that we have pretty exciting numbers for Partnering companies (already!), and partly because we’re just really looking forward to launching! So how early? It looks like it will be this coming Monday, April 11th. If you’ve Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

IPO Update – April 5th, 2011

The six biotech IPOs of 2011 have followed 2010′s IPO trends; all took significant haircuts getting out the door and most are performing modestly.  The median downward adjustment in the amount raised for 2011′s biotech IPOs stands at -31%, the average is at -33%.  These companies have raised a median and mean amount of $49M and $54M, respectively. Despite the lukewarm IPO reception biotech stocks have faced in the U.S., two more U.S. companies have filed to go public since the close of 2010.  Specialty pharmaceutical Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

The BTK buyout

Remember this BTK post we wrote back  in February of 2010?  Well, we thought it was time to revisit the makeup of the BTK index (NYSE Arca Biotechnology Index).  Five of  the 20 companies that comprised the index in February of last year have either been acquired or are facing acquisition.  That means 25% of the entire index has been snapped up in a little over a year (Table 1). Millipore (MIL) and OSI Pharmaceuticals (OSIP) acquired in 2010 by Merck KGaA and Astellas, respectively, have already Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,